VAREX IMAGING (VREX) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving.The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this company, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions ...

Shares of VAREX IMAGING (VREX) have gained 23.2% over the past four weeks to close the last trading session at $9.77, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $16.75 indicates a potential upside of 71.4%.The average comprises four short-term price targets ranging from a low of $10.00 to a high of $23.00, with a standard deviation of $5.38. While the lowest estimate indica ...

For the quarter ended June 2025, VAREX IMAGING (VREX) reported revenue of $203 million, down 2.9% over the same period last year. EPS came in at $0.18, compared to $0.14 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $190.2 million, representing a surprise of +6.73%. The company delivered an EPS surprise of +350%, with the consensus EPS estimate being $0.04.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how th ...

VAREX IMAGING (VREX) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.14 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +350.00%. A quarter ago, it was expected that this company would post earnings of $0.14 per share when it actually produced earnings of $0.26, delivering a surprise of +85.71%.Over the last four quarters, the company ...

Varex Imaging (VREX) Q3 2025 Earnings Call August 07, 2025 05:00 PM ET Speaker0Greetings, and welcome to the Varex Third Quarter Fiscal Year twenty twenty five Earnings Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Chris Belfoury.Thank you. You may begin.Speaker1Good afternoon and welcome to Varex Imaging Corporation's earnings c ...

8/7/2025 1 Making the Invisible Visible Certain information provided in this presentation includes financial measurements that are not required by, or presented in accordance with, generally accepted accounting principles in the United States (GAAP). These non-GAAP measures, such as non-GAAP gross margin, non-GAAP operating expense, non-GAAP operating margin, and non- comparable to, similarly titled measures used at other companies. For a reconciliation to the most directly comparable GAAP financial measure ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 4, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 ____________________________________________________________ VAREX IMAGING CORPORATI ...

Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER FISCAL YEAR 2025 SALT LAKE CITY, August 7, 2025 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the third quarter of fiscal year 2025. 3QFY25 Summary Sunny Sanyal, Chief Executive Officer, stated, "We are pleased to report that third quarter revenue of $203 million was above the high-end of our guidance. Our Industrial segment remained strong in the quarter and Medical revenue in China was better ...

Summary of Varex Imaging (VREX) Conference Call Company Overview - Varex Imaging is a market leader in imaging components for x-ray based imaging systems, primarily in the medical sector, which constitutes approximately 78-80% of its business [2][3][4]. Core Value Proposition - Varex's competitive advantage lies in its significant investment in innovation, having invested over $1 billion in foundational technologies over the past 20 years, which most OEMs lack [3][4]. - The company employs around 500 people in x-ray product development and holds approximately 600 patents, allowing it to provide bespoke components that help OEMs bring products to market faster [4][5]. Market Trends - The trend in the industry is shifting towards outsourcing rather than insourcing, with Varex working with a wide range of OEMs, including emerging players in markets like India and China [6][7][8]. - The company identifies future winners among OEMs and partners with them, which has been a successful strategy over the years [6][7]. Recent Financial Performance - Varex reported strong fiscal 2Q results, exceeding consensus on revenue, gross margin, and EPS, with a recovery in demand following a period of channel inventory adjustments [10][12]. - The company noted that the audit situation in Chinese hospitals and destocking issues had improved, leading to solid order coverage [12][13]. Tariff Impact and Mitigation Strategies - The tariff situation has been turbulent but is moving in a positive direction, with current tariffs at about 55% for input materials [16][17]. - Varex is implementing several mitigation strategies, including passing on input costs to customers, diversifying its supply chain, and regionalizing manufacturing to enhance resilience [20][21][36]. Manufacturing Developments - Varex is progressing with two factories in India: one for detectors expected to start shipping in 3-4 months, and another for tubes, which is 12-15 months away from production [31][32]. Customer Relationships - Canon remains Varex's top customer, contributing 17-18% of annual revenues, with a stable relationship focused on ongoing R&D projects [51][53]. - The company has observed a healthy demand for its products, with a significant installed base ensuring continued orders for replacement components [25][54]. End Market Dynamics - The medical segment has shown stability, with channel inventory returning to normal operating conditions [47][49]. - In the industrial segment, Varex has seen faster growth compared to medical, driven by demand in global security and cargo inspection markets [60][61]. Direct-to-Customer Opportunities - Varex's direct-to-customer industrial inspection business has shown promising growth, with significant orders in the cargo inspection systems space, which is a billion-dollar addressable market [62][63]. Competitive Landscape - Varex differentiates itself through vertical integration, being one of only two companies globally with this capability, which enhances its innovation and product tailoring [63][64]. Conclusion - Varex Imaging is well-positioned in the imaging components market, leveraging its innovation, strong customer relationships, and strategic responses to market dynamics and challenges, including tariffs and supply chain issues. The company is optimistic about future growth in both medical and industrial sectors.

Group 1 - VAREX IMAGING reported $212.9 million in revenue for the quarter ended March 2025, a year-over-year increase of 3.3% [1] - The EPS for the same period was $0.26, compared to $0.16 a year ago, indicating a significant improvement [1] - The reported revenue exceeded the Zacks Consensus Estimate of $206.83 million by 2.93%, and the EPS surprised by 85.71% against the consensus estimate of $0.14 [1] Group 2 - VAREX IMAGING's Industrial revenues were $59.10 million, slightly below the estimated $59.12 million, reflecting a 3% year-over-year change [4] - Medical revenues reached $153.80 million, surpassing the average estimate of $147.36 million, marking a 3.4% increase year-over-year [4] - Gross profit for Industrial was $20.80 million, exceeding the estimated $19.64 million, while Medical gross profit was $55.90 million, above the estimated $48.61 million [4] Group 3 - VAREX IMAGING shares have returned -6% over the past month, contrasting with the Zacks S&P 500 composite's +11.3% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]